A pharmacoepidemiology study of local fungal infections in skin and venereal diseases outpatient department of a rural tertiary care hospital


  • Preety Bansal Department of Pharmacology, Maharaja Agrasen Medical College, Agroha, Haryana, India
  • Seema Baishnab Department of Pharmacology, Maharaja Agrasen Medical College, Agroha, Haryana, India




Fungal infections, Itraconazole, Ketoconazole, Tinea cruris


Background: Fungal infections of the skin were the 4th most common skin disease in 2010 affecting 984 million people. An estimated 20-25% of the world’s population has some form of fungal infection. Dermatophytes are fungi that cause superficial infections of the skin, commonly referred to as tinea infections.

Methods: This was a prospective and an observational study conducted from February 2018 to January 2019 in Dermatology Department. Prescriptions included all newly diagnosed patients with cutaneous fungal infection of both sex who attended dermatology OPD. Factors considered were sociodemographic parameters, the disease encountered and number of patients in each group and number of patients who received antifungal therapy (oral and topical) etc.

Results: 1000 prescriptions were analysed of patients between 18 to 65 years of age with cutaneous fungal infections. There were a greater number of males (57.4%) than females (42.6%). The average number of antifungal drugs prescribed per prescription was 2.33. Majority of the patients were prescribed itraconazole (82.30%) followed by terbinafine (9.70%) and fluconazole (8.0%).

Conclusions: The most common oral antifungal drug used was itraconazole. Ketoconazole and Terbinafine were the most commonly used topical agents respectively.


James WD, Elston DM, Berger TG. Andrew’s diseases of the skin clinical dermatology. 12th ed. Philadelphia: Elsevier; 2016:285.

Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: An analysis of the prevalence and impact of skin conditions. J Investig Dermatol. 2013;134:1527-34.

Lakshmanan A, Ganeshkumar P, Raam Mohan S, Hemamalini M, Madhavan R. Epidemiological and clinical pattern of dermatomycoses in rural India. Indian J Med Microbiol. 2015;33(5):134-6.

Al Balushi KA, Alzaabi MA, Alghafri F. Prescribing pattern of antifungal medications at atertiary care hospital in Oman. J Clin Diagn Res. 2016;10(12):FC27-30.

Rezabek GH, Friedman AD. Superficial fungal infections of the skin diagnosis and current treatment recommendations. Drugs. 1992;43(5):674-82.

Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology. 7th ed. Philadelphia: Elsevier; 2013:631.

Rang HP, Ritter JM, Flower RJ, Henderson G. Rang & dale’s pharmacology. 8th ed. Elsevier; 2012:654.

Rogers PD, Krysan DJ. Antifungal agents. In: Brunton LL, Dandan RH, Knollmann BC, eds. Goodman and Gillman’s the pharmacological basis of therapeutics thirteenth edition. New York: McGraw-Hill; 2018:1091.

Tripathi KD. Essentials of medical pharmacology. 7th ed. New Delhi: Jaypee Publication; 2013:790-1.

Patil A, Dighe D, Kolte S, Jadhav PR, Deshmukh YA. Drug utilization pattern in dermatology outpatient department at a tertiary care hospital in Navi Mumbai. Int J Basic Clin Pharmacol. 2017;6(3):559-62.

George AJ, Godbole D, Mali M, Pawar S. Assessment of etiology pattern and treatment of tinea infections in a tertiary care hospital. Advanc Med Dental Health Sci. 2018;1(1):8-11.

Jain N, Sharma M, Sharma M, Saxena VM. Spectrum of dermatophytosis in Jaipur. Afr J Microbiol. 2014;8(3):237-43.

Shukla P, Yaqoor S, Shukla V, Garg J, Dar ZP, Haider F. Prevalence of superficial mycosis among outdoor patients in a tertiary care hospital. Nat J Med Sci. 2013;2(2):19-26.

Vegada BN, Karelia BN, Singh AP. Drug utilization study of antifungal agents used in department of skin and V.D. of a tertiary care teaching hospital. Int J Pharm Sci Rev Res. 2015;34(1):118-21.

Andrea C, Pires A, Lobato AM, Regina F, Carneiro O. Clinical, epidemiological, and therapeutic profile of dermatophytosis. An Bras Dermatol. 2014;89(2):259 -65.

Koshley V, Halwai AK, Koshley SB, Kurrey PK, Jaiswal S. Treatment pattern of dermatophytosis at the outpatient clinic of a tertiary healthcare hospital of Chhattisgarh, central India. Indian J Clin Exp Dermatol. 2018;4(4):327-30.

Rengasamy M, Chellam J, Ganapati S. Systemic therapy of dermatophytosis: practical and systematic approach. Clin Dermatol Rev. 2017;1:S19-23.

Kaur M, Sumir Kumar S, Singh P. A cost analysis study on drug prescribing pattern of antifungal in dermatological conditions at tertiary care teaching hospital, Punjab. Eur J Pharm Med Res. 2017;4(4):461-4.

Gopimohan P, Sudha MJ, Pillai RT, Ramani PT. A study on the prescription pattern of antifungal drugs in the dermatology department of a tertiary care teaching hospital in southern Kerala. Int J Basic Clin Pharmacol. 2019;8(1):100-103.

Pathak AK, Kumar S, Kumar M, Mohan L, Dikshit H. Study of drug utilization pattern for skin diseases in dermatology opd of an Indian tertiary care hospital- a prescription survey. J Clin Diagn Res. 2016;10(2):FC0105.

Kumar J, Chandra S, Sinha HK. Utilization pattern of drugs among dermatological outpatients in a tertiary care hospital of eastern India. Int J Clin Pharmacol Res. 2016;6(9):297-302.




How to Cite

Bansal, P., & Baishnab, S. (2020). A pharmacoepidemiology study of local fungal infections in skin and venereal diseases outpatient department of a rural tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 9(4), 616–620. https://doi.org/10.18203/2319-2003.ijbcp20201187



Original Research Articles